Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenal Artery Ablation for Uncontrolled Hypertension
NCT03660397Phase 3Unknown
- Sponsor
- Army Medical University
- Start
- Aug 2018
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Army Medical University. Primary endpoint: Change of 24-h average systolic blood pressure at 24 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT03660397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03660397.